Rigel Pharmaceuticals, Inc. (RIGL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 770.38M |
| Enterprise Value | 783.11M |
| P/E Ratio | 2.77 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 3.3 |
| Price/Book Ratio | 2.13 |
| Enterprise/Revenue | 3.22 |
| Enterprise/EBITDA | 9.49 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 1.16 |
| Operating Margin | 0.31 |
AD
Management Effectiveness
| Return On Assets | 0.62 |
| Return On Equity | 0.96 |
Income Statement
| Revenue | 294.28M |
| Revenue/Share | 14.93 |
| Gross Profit | 274.66M |
| EBITDA | 131.56M |
| Net Income | 367.02M |
| Diluted EPS | 19.48 |
Balance Sheet
| Total Cash | 95.33M |
| Total Cash/Share | 5.14 |
| Total Debt | 39.95M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 1.95 |
| Book Value Per Share | 22.96 |
Price History
| 52-Week Change | 59.27 |
| 52-Week High | 52.24 |
| 52-Week Low | 24.95 |
| Moving Average 50 Days | 46.74 |
| Moving Average 200 Days | 36.86 |
Statistics
| Average Volume | 271,815 |
| Shares Outstanding | 18.68M |
| % Held by Institutions | 89.82 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 27, 2024 |
AD
